✦ LIBER ✦

NICE recommends alemtuzumab for MS

Book ID: 125387418
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 2014
Weight: 199 KB
Volume: 704
Category: Article
ISSN: 1173-5503
DOI: 10.1007/s40274-014-1302-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Natalizumab recommended by NICE for rela

Natalizumab recommended by NICE for relapsing-remitting MS

📂 Article 📅 2007 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

NICE recommends canagliflozin for T2DM

✍ Coker, Kendell L.; Rosenheck, Robert 📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB

NICE recommends rituximab for follicular

NICE recommends rituximab for follicular lymphoma . . .

📂 Article 📅 2006 🏛 Adis International Limited (now part of Wolters Kl ⚖ 120 KB

NICE recommends aflibercept for macular

NICE recommends aflibercept for macular oedema . . .

✍ Yu, Xingwang; Peng, Hui; Liu, Yanmin; Zhang, Yan; Shu, Yingjie; Chen, Quanjia; S 📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 200 KB

NICE recommends aflibercept for macular

NICE recommends aflibercept for macular oedema . . .

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 200 KB

NICE recommends enzalutamide for prostat

NICE recommends enzalutamide for prostate cancer

📂 Article 📅 2014 🏛 Adis International Limited (now part of Wolters Kl ⚖ 199 KB